BG105803A - Epotylon derivatives, method for their production and pharmaceutical use thereof - Google Patents
Epotylon derivatives, method for their production and pharmaceutical use thereofInfo
- Publication number
- BG105803A BG105803A BG105803A BG10580301A BG105803A BG 105803 A BG105803 A BG 105803A BG 105803 A BG105803 A BG 105803A BG 10580301 A BG10580301 A BG 10580301A BG 105803 A BG105803 A BG 105803A
- Authority
- BG
- Bulgaria
- Prior art keywords
- methyl
- pyridyl
- oxazolyl
- thiazolyl
- atom
- Prior art date
Links
- -1 2-methyl-4-thiazolyl Chemical group 0.000 abstract 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 5
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 abstract 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 4
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 2
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1999107480 DE19907480A1 (de) | 1999-02-11 | 1999-02-11 | Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung |
| DE19954229A DE19954229A1 (de) | 1999-11-04 | 1999-11-04 | Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung |
| PCT/EP2000/001104 WO2000047584A2 (de) | 1999-02-11 | 2000-02-11 | Epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG105803A true BG105803A (en) | 2002-03-29 |
Family
ID=26051977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG105803A BG105803A (en) | 1999-02-11 | 2001-08-09 | Epotylon derivatives, method for their production and pharmaceutical use thereof |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7001916B1 (de) |
| EP (1) | EP1161430A2 (de) |
| JP (1) | JP2002536450A (de) |
| KR (1) | KR20010094763A (de) |
| CN (1) | CN1340053A (de) |
| AU (1) | AU4101800A (de) |
| BG (1) | BG105803A (de) |
| BR (1) | BR0008206A (de) |
| CA (1) | CA2360952A1 (de) |
| CZ (1) | CZ20012886A3 (de) |
| EA (1) | EA200100833A1 (de) |
| EE (1) | EE200100422A (de) |
| HK (1) | HK1044946A1 (de) |
| HU (1) | HUP0105330A2 (de) |
| IL (1) | IL144370A0 (de) |
| MX (1) | MXPA01008148A (de) |
| NO (1) | NO20013900L (de) |
| PL (1) | PL350190A1 (de) |
| SK (1) | SK11452001A3 (de) |
| WO (1) | WO2000047584A2 (de) |
| YU (1) | YU57601A (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0977563B1 (de) | 1996-12-03 | 2005-10-12 | Sloan-Kettering Institute For Cancer Research | Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon |
| US6204388B1 (en) | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US6660758B1 (en) * | 1996-12-13 | 2003-12-09 | The Scripps Research Institute | Epothilone analogs |
| US7125893B1 (en) * | 1999-04-30 | 2006-10-24 | Schering Ag | 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| AU2002308218B2 (en) * | 2001-02-27 | 2005-11-10 | Novartis Ag | Combination comprising a signal transduction inhibitor and an epothilone derivative |
| BR0212107A (pt) * | 2001-08-23 | 2004-08-24 | Novartis Ag | Análogos da ciclopropil e da ciclobutil epotilona |
| DK1483251T3 (da) | 2002-03-12 | 2010-04-12 | Bristol Myers Squibb Co | C3-cyano-epothilon-derivater |
| BR0311714A (pt) * | 2002-06-10 | 2005-03-01 | Novartis Ag | Combinações que compreendem epotilonas e seus usos farmacêuticos |
| RU2379032C9 (ru) * | 2002-06-10 | 2010-03-27 | Новартис Аг | Комбинации, включающие эпотилоны, и их фармацевтическое применение |
| RU2338741C2 (ru) * | 2002-07-31 | 2008-11-20 | Мершан Корпорейшн | Новые физиологически активные вещества |
| US20050215604A1 (en) * | 2004-03-26 | 2005-09-29 | Kosan Biosciences, Inc. | Combination therapies with epothilones and carboplatin |
| EP1589011A1 (de) * | 2004-04-22 | 2005-10-26 | Schering Aktiengesellschaft | Neue chirale Heptin Derivate zur Herstellung von Epothilonen und Verfahren zu deren Herstellung |
| EP1856255A4 (de) | 2005-02-11 | 2010-01-27 | Univ Southern California | Verfahren zur expression von proteinen über disulfidbrücken |
| EP2029156A4 (de) * | 2006-05-01 | 2010-07-21 | Univ Southern California | Kombinationstherapie zur krebsbehandlung |
| US20100113128A1 (en) * | 2008-11-05 | 2010-05-06 | Snow Richard N | Methods and apparatus for determining a reel strip position |
| US8802394B2 (en) | 2008-11-13 | 2014-08-12 | Radu O. Minea | Method of expressing proteins with disulfide bridges with enhanced yields and activity |
| US20100125146A1 (en) * | 2008-11-19 | 2010-05-20 | Johnson Matthey Public Limited Company | Method for making pharmaceutical compounds |
| CA2799202C (en) | 2010-05-18 | 2016-07-05 | Cerulean Pharma Inc. | Compositions and methods for treatment of autoimmune and other diseases |
| EP3371176A4 (de) * | 2015-10-16 | 2019-09-04 | William Marsh Rice University | Epothilon-analoga, syntheseverfahren, behandlungsverfahren und arzneimittelkonjugate dafür |
| WO2017096559A1 (en) | 2015-12-09 | 2017-06-15 | Rhodia Operations | Production of xylene derivatives |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4138042C2 (de) | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel |
| US5469145A (en) | 1992-05-29 | 1995-11-21 | Johnson; Lonnie | Wet diaper detector |
| EP1440973A3 (de) | 1995-11-17 | 2004-10-20 | Gesellschaft für biotechnologische Forschung mbH (GBF) | Epothilonderivate, Herstellung und Mittel |
| US6441025B2 (en) | 1996-03-12 | 2002-08-27 | Pg-Txl Company, L.P. | Water soluble paclitaxel derivatives |
| US5969145A (en) | 1996-08-30 | 1999-10-19 | Novartis Ag | Process for the production of epothilones and intermediate products within the process |
| WO1998008849A1 (de) | 1996-08-30 | 1998-03-05 | Novartis Aktiengesellschaft | Verfahren zur herstellung von epothilonen und zwischenprodukte innerhalb des verfahrens |
| DE19636343C1 (de) | 1996-08-30 | 1997-10-23 | Schering Ag | Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B |
| US6867305B2 (en) * | 1996-12-03 | 2005-03-15 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| EP0977563B1 (de) | 1996-12-03 | 2005-10-12 | Sloan-Kettering Institute For Cancer Research | Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon |
| US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
| DE19701758A1 (de) | 1997-01-20 | 1998-07-23 | Wessjohann Ludgar A Dr | Epothilone-Synthesebausteine |
| US6605599B1 (en) * | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
| JP2001512723A (ja) * | 1997-08-09 | 2001-08-28 | シエーリング アクチエンゲゼルシヤフト | 新規エポチロン誘導体、その製法およびその薬学的使用 |
| WO1999067253A2 (en) | 1998-06-22 | 1999-12-29 | Novartis Ag | Desmethyl epothilones |
| AU6208701A (en) | 2000-03-09 | 2001-09-17 | Schering Aktiengesellschaft | Radioactively labeled epothilone derivatives, method for the production thereof, and their biochemical and pharmaceutical use |
| CA2359267A1 (en) | 2000-10-19 | 2002-04-19 | Manabu Takami | Wavelength selecting module and wavelength selecting apparatus |
| EP1340498A1 (de) * | 2002-03-01 | 2003-09-03 | Schering Aktiengesellschaft | Verwendung von Epothilonen zur Behandlung von mit proliferativen Prozessen assoziierten Gehirnerkrankungen |
| PL374528A1 (en) * | 2002-07-31 | 2005-10-31 | Schering Aktiengesellschaft | New effector conjugates, process for their production and their pharmaceutical use |
| WO2004015088A2 (en) | 2002-08-13 | 2004-02-19 | Kosan Biosciences, Inc. | Transposon-based transformation system |
-
2000
- 2000-02-11 PL PL00350190A patent/PL350190A1/xx not_active Application Discontinuation
- 2000-02-11 HK HK02106492.8A patent/HK1044946A1/zh unknown
- 2000-02-11 KR KR1020017010109A patent/KR20010094763A/ko not_active Withdrawn
- 2000-02-11 AU AU41018/00A patent/AU4101800A/en not_active Abandoned
- 2000-02-11 EP EP00920433A patent/EP1161430A2/de not_active Withdrawn
- 2000-02-11 WO PCT/EP2000/001104 patent/WO2000047584A2/de not_active Ceased
- 2000-02-11 JP JP2000598504A patent/JP2002536450A/ja active Pending
- 2000-02-11 US US09/913,163 patent/US7001916B1/en not_active Expired - Fee Related
- 2000-02-11 CA CA002360952A patent/CA2360952A1/en not_active Abandoned
- 2000-02-11 YU YU57601A patent/YU57601A/sh unknown
- 2000-02-11 EA EA200100833A patent/EA200100833A1/ru unknown
- 2000-02-11 SK SK1145-2001A patent/SK11452001A3/sk unknown
- 2000-02-11 CN CN00803717A patent/CN1340053A/zh active Pending
- 2000-02-11 MX MXPA01008148A patent/MXPA01008148A/es unknown
- 2000-02-11 BR BR0008206-6A patent/BR0008206A/pt not_active IP Right Cessation
- 2000-02-11 EE EEP200100422A patent/EE200100422A/xx unknown
- 2000-02-11 CZ CZ20012886A patent/CZ20012886A3/cs unknown
- 2000-02-11 IL IL14437000A patent/IL144370A0/xx unknown
- 2000-02-11 HU HU0105330A patent/HUP0105330A2/hu unknown
-
2001
- 2001-08-09 BG BG105803A patent/BG105803A/xx unknown
- 2001-08-10 NO NO20013900A patent/NO20013900L/no not_active Application Discontinuation
-
2005
- 2005-07-27 US US11/189,787 patent/US20060040990A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1161430A2 (de) | 2001-12-12 |
| BR0008206A (pt) | 2002-02-19 |
| MXPA01008148A (es) | 2003-07-21 |
| NO20013900D0 (no) | 2001-08-10 |
| JP2002536450A (ja) | 2002-10-29 |
| EE200100422A (et) | 2002-12-16 |
| PL350190A1 (en) | 2002-11-18 |
| SK11452001A3 (sk) | 2002-04-04 |
| YU57601A (sh) | 2005-06-10 |
| US7001916B1 (en) | 2006-02-21 |
| CN1340053A (zh) | 2002-03-13 |
| AU4101800A (en) | 2000-08-29 |
| HUP0105330A2 (hu) | 2002-05-29 |
| WO2000047584A3 (de) | 2000-12-28 |
| NO20013900L (no) | 2001-10-11 |
| CA2360952A1 (en) | 2000-08-17 |
| CZ20012886A3 (cs) | 2001-11-14 |
| WO2000047584A2 (de) | 2000-08-17 |
| KR20010094763A (ko) | 2001-11-01 |
| US20060040990A1 (en) | 2006-02-23 |
| EA200100833A1 (ru) | 2002-02-28 |
| HK1044946A1 (zh) | 2002-11-08 |
| IL144370A0 (en) | 2002-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG105803A (en) | Epotylon derivatives, method for their production and pharmaceutical use thereof | |
| HUP0302380A2 (hu) | Cisztein-proteázok reverzibilis inhibitoraiként alkalmazható új spiroheterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0302274A2 (hu) | 2,4,8-Triszubsztituált-8H-pirido[2,3-d]pirimidin-7-on-vegyületek és felhasználásuk CSBP/p38 kináz által mediált betegségek kezelésére, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0302167A2 (hu) | Metabotropikus glutamát receptor antagonista hatású kinolinszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
| HUP0303756A2 (hu) | 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0303037A2 (hu) | Alzheimer-kór kezelésére alkalmas vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
| HUP9901652A2 (hu) | Piperidin-karbonsav-származékok alkalmazása vérglükózkoncentráció csökkentésére alkalmas gyógyszerkészítmények előállítására | |
| HUP0102084A2 (hu) | Kinolinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| HUP0303283A2 (hu) | Új piridinilcsoporttal szubsztituált pirazolopiridin-származékok, előállításuk és alkalmazásuk szív- és keringési betegségek kezelésére alkalmas gyógyszerkészítmény előállítására | |
| HUP0301389A2 (hu) | Purinszármazékok | |
| HUP0204431A1 (hu) | 1,5-Diszubsztituált-3,4-dihidro-1H-pirimido[4,5-d]pirimidin-2-on-vegyületek és falhasználásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| AR047557A1 (es) | Compuestos derivados de piridazina y su uso como agentes terapeuticos | |
| HUP0300693A2 (hu) | Eljárás epotilon-analógok és -intermedierek előállítására | |
| ATE247654T1 (de) | Neue heterozyklische verbindungen | |
| ATE123771T1 (de) | Stickstoff enthaltende heterozyklische verbindungen, ihre herstellung und verwendung. | |
| ATE387199T1 (de) | Neue substanzen und verbindungen als protease- inhibitoren | |
| DE60004564D1 (de) | Neue piperidin und piperazin-derivate als p2x7-rezeptor antagonisten | |
| ATE139233T1 (de) | Annelierte thiophen-derivate, ihre herstellung und verwendung | |
| HUP0204354A2 (hu) | Új heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DE60011889D1 (en) | 2,4-diamino-3-hydroxycarboxylsäurederivate als proteasome inhibitoren | |
| HUP0204394A2 (en) | Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same | |
| TR200002831A2 (tr) | Kinolin-4-İl türevleri I | |
| ATE211137T1 (de) | Substituierte benzylthienylpiperazine, ihre anwendung als arzneimittel und verfahren für ihre herstellung | |
| DE69315363D1 (de) | Amphotere tricyclische Verbindungen als antihistaminische und antiallergische Mittel | |
| ATE502030T1 (de) | Imidazolderivate, verfahren zu deren herstellung und deren verwendung |